Search
for
Sort by
Research 871–900 of 1000+
- Management of women with hirsutism in Kosovo
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- A Natural Product Molecule of Artocarpus Heterophyllus Reverses Inflammation Due to the Effect of Acute Exposure of Prostate Tissue to Testosterone Enanthate in Wistar Rats
- Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Postmenopausal Alopecia (Hair Loss)
- Azathioprine: A therapy to be considered in alopecia universalis
- Diphencyprone in the treatment of Satoyoshi syndrome
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- Aknede Hormonal Tedavi
- Polycystic ovarian syndrome
- Mechanistic synergy of hair growth promotion by the Avicennia marina extract and its active constituent (avicequinone C) in dermal papilla cells isolated from androgenic alopecia patients
- Frontal fibrosing alopecia: a survey in 16 patients
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Managing polycystic ovary syndrome in primary care
- Current treatment of BPH
- Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial
- EFFICACY OF FLAXSEED CRACKERS IN AMELIORATING CLINICAL AND BIOCHEMICAL HYPERANDROGENISM IN YOUNG ADULT SOUTH INDIAN WOMEN DIAGNOSED WITH PCOS
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
- Efectos del minoxidilo en formulación oral en pacientes barosensibles
- Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey
- Efficacy and safety of a botanical shampoo containing <i>Morus alba</i> root extract in Republic of Korea: a single-center, open-label, pilot study in mild to moderate non-scarring alopecia of the scalp
- Common Causes of Hair Loss and Their Treatment Options